Ftse Mib
38.655,09
0,08%
DAX
22.551,43
0,12%
S&P 500
5.954,50
1,59%
NASDAQ
18.847,28
1,63%
Bitcoin
85.234,86
1,03%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ ANI Pharmaceuticals Inc (ANIP) ANI Pharmaceuticals Inc (ANIP) Notizie

ANI Pharmaceuticals Inc

ANIP
61,89
7,31 (13,39%)
01 Mar 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
28/2/202513:05EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28/2/202512:55EDGAR2Form 8-K - Current report
28/2/202512:50GLOBEANI Pharmaceuticals Reports Record Fourth Quarter and..
24/2/202522:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/2/202522:30GLOBEANI Pharmaceuticals to Present at Raymond James’..
19/2/202502:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/2/202502:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/2/202502:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/2/202502:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/2/202502:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/2/202502:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/2/202502:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/2/202522:05GLOBEANI Pharmaceuticals to Discuss Fourth Quarter and Full Year..
05/2/202513:00EDGAR2Form 8-K - Current report
28/1/202522:30GLOBEANI Pharmaceuticals to Present at the Guggenheim Biotech..
21/1/202522:04EDGAR2Form SCHEDULE 13G - Statement of Beneficial Ownership by..
13/1/202522:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/1/202517:12PRNUSAlcami Announces CEO Transition
13/1/202512:50GLOBEANI Pharmaceuticals Provides Preliminary Fourth Quarter and..
02/1/202512:50GLOBEANI Pharmaceuticals Announces the FDA Approval and Launch of..
30/12/202422:05GLOBEANI Pharmaceuticals to Present at the 43rd Annual J.P...
18/12/202423:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/12/202423:35EDGAR2Form 144 - Report of proposed sale of securities
16/12/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202423:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202401:44EDGAR2Form 144 - Report of proposed sale of securities
26/11/202422:30GLOBEANI Pharmaceuticals to Present at 36th Annual Piper Sandler..
20/11/202413:00EDGAR2Form 8-K - Current report
18/11/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202422:30EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
08/11/202414:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202412:55EDGAR2Form 8-K - Current report
08/11/202412:50GLOBEANI Pharmaceuticals Reports Record Third Quarter 2024..
04/11/202422:30GLOBEANI Pharmaceuticals to Present at Guggenheim's Inaugural..
30/10/202422:00GLOBEANI Pharmaceuticals to Discuss Third Quarter 2024 Financial..
25/10/202412:50GLOBEANI Pharmaceuticals Announces the FDA Approval and Launch of..
24/10/202412:50GLOBEANI Pharmaceuticals to Present New Data Highlighting..
15/10/202423:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202412:50GLOBEANI Pharmaceuticals Announces the FDA Approval and Launch of..
20/9/202422:03EDGAR2Form 8-K - Current report
16/9/202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/9/202415:13EDGAR2Form 8-K - Current report
16/9/202414:53GLOBEANI Pharmaceuticals, Inc. Completes Acquisition of Alimera..
16/9/202412:50GLOBEANI Pharmaceuticals Initiates Closing of Acquisition of..
13/9/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202412:50GLOBEANI Pharmaceuticals Launches Promethazine Hydrochloride and..
11/9/202412:50BWANI Pharmaceuticals and Alimera Sciences Announce Closing..
Apertura: 61,00 Min: 58,00 Max: 62,617
Chiusura: 54,58

La tua Cronologia

NASDAQ
ANIP
ANI Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci